previous
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial
next
Poster | Challenges Faced by Adolescent Girls in Uganda that Affected Timely Delivery of HIV Prevention Services; Observational Findings from HPTN 084-01 Study at Kampala, MU-JHU Site.
© 2022 MU-JHU Research Collaboration. All rights reserved